Advertisement

Phoniatrics I pp 751-836 | Cite as

Basics of Disorders of Hearing Development

  • Antoinette am Zehnhoff-DinnesenEmail author
  • Wendy Albuquerque
  • Hanno J. Bolz
  • Steffi Johanna Brockmeier
  • Thorsten Langer
  • Radha Narayan
  • Ross Parfitt
  • Simona Poisson-Markova
  • Ewa Raglan
  • Sabrina Regele
  • Rainer Schönweiler
  • Pavel Seeman
  • Eva Seemanova
  • Amélie Elisabeth Tillmanns
  • Oliver Zolk
Chapter
Part of the European Manual of Medicine book series (EUROMANUAL)

Abstract

After the definition of hearing loss, audiological grading scales defining the presence and severity of hearing loss are presented. An overview is provided of epidemiological estimates of childhood hearing loss and issues involved in their calculation. After specification of the stages of hearing development, the different types of behavioural responses to sound that develop in normal children are described. An overview of the normal stages of speech and language development in normal-hearing children is followed by the impact of different kinds and degrees of hearing loss on speech and language acquisition of hearing-impaired children.

Risk factors for permanent childhood hearing impairment are listed, and likely additional disabilities are referred to. Infections with neurotropic viruses presenting complications and immunisation strategies are highlighted. A further aetiological key aspect concerns ototoxic side effects of anticancer drugs, anti-infective agents, loop diuretics and ototopical medications, which are presented in context with audiological diagnostics, monitoring and post-therapeutic follow-up, therapeutic options and preventive strategies. A third core area is related to syndromic and non-syndromic forms of hereditary hearing loss. More than 60 hearing loss syndromes are specified with their affected genes and chromosomal regions. Clinical manifestations with possible impact on hearing, ear-specific anomalies, the type of hearing impairment and cognitive function are described.

Keywords

Definition Impact Audiological grading scales Epidemiology Development stages Aetiology 

References

  1. Acke FRE, Dhooge IJM, Malfait F et al (2012) Hearing impairment in Stickler syndrome: a systematic review. Orphanet J Rare Dis 7:84.  https://doi.org/10.1186/1750-1172-7-84CrossRefPubMedPubMedCentralGoogle Scholar
  2. Allanson JE, Roberts AE (2016) Noonan syndrome. In: Pagon RA et al (ed) GeneReviews® [Internet]. Available via https://www.ncbi.nlm.nih.gov/books/NBK1124. Accessed 3 June 2017
  3. Alnahwi M, AlQudehy ZA (2015) Comparison between frequency transposition and frequency compression hearing aids. Egypt J Otolaryngol 31(1):10–18CrossRefGoogle Scholar
  4. Alves C, Silva Oliveira C (2014) Hearing loss among patients with Turner’s syndrome: literature review. Braz J Otorhinolaryngol 80(3):257–263PubMedCrossRefPubMedCentralGoogle Scholar
  5. American Academy of Pediatrics Committee on Genetics (2008) Maternal Phenylketonuria Committee on Genetics Policy Statement. Available via http://pediatrics.aappublications.org/content/pediatrics/122/2/445.full.pdf. Accessed 1 May 2017
  6. American Speech-Language-Hearing Association (2005) How does your child hear and talk? Available via http://www.asha.org/public/speech/development/chart/. Accessed 14 July 2017
  7. American Speech-Language-Hearing Association ASHA (1994) Audiologic management of individuals receiving cochleotoxic drug therapy.  https://doi.org/10.1044/policy.GL1994-00003. Accessed 30 Dec 2016
  8. Amir J, Wolf DG, Levy I (2010) Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur J Pediatr 169(9):1061–1067PubMedCrossRefPubMedCentralGoogle Scholar
  9. Asatryan A, Pool V, Chen RT et al (2008) Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, GA, USA, The VAERS Team. Live attenuated measles and mumps viral strain containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990-2003. Vaccine 26(9):1166–1172PubMedCrossRefPubMedCentralGoogle Scholar
  10. Austeng ME, Akre H, Falkenberg ES et al (2013) Hearing level in children with Down Syndrome at the age of eight. Res Dev Disabil 34(7):2251–2256PubMedCrossRefPubMedCentralGoogle Scholar
  11. BAAP (2015a) Guidelines for aetiological investigation into unilateral permanent childhood hearing impairment. Available via http://www.baap.org.uk/Portals/0/Guidelines%20for%20aetiological%20investigation%20into%20unilateral%20permanent%20childhood%20hearing%20impairment.pdf. Accessed 17 May 2017
  12. BAAP (2015b) Guidelines for aetiological investigation into severe to profound bilateral permanent childhood hearing impairment. Available via http://www.baap.org.uk/Portals/0/Guidelines%20for%20aetiological%20investigation%20into%20severe%20to%20profound%20bilateral%20permanent%20childhood%20hearing%20impairment.pdf. Accessed 17 May 2017
  13. BAAP (2015c) Guidelines for aetiological investigation into mild to moderate bilateral permanent childhood hearing impairment. Available via http://www.baap.org.uk/Portals/0/Guidelines%20for%20aetiological%20investigation%20into%20mild%20to%20moderate%20bilateral%20permanent%20childhood%20hearing%20impairment.pdf. Accessed 17 May 2017
  14. Babu SC, Kartush JM, Patni A (2005) Otologic effects of topical mitomycin C: phase I-evaluation of ototoxicity. Otol Neurotol 26(2):140–144PubMedCrossRefPubMedCentralGoogle Scholar
  15. Bahmad F Jr, Merchant SN, Nadol JB et al (2007) Otopathology in Mohr-Tranebjaerg syndrome. Laryngoscope 117(7):1202–1208PubMedPubMedCentralCrossRefGoogle Scholar
  16. Bahmad F Jr, Costa CS, Teixeira MS et al (2014) Familial Alström syndrome: a rare cause of bilateral progressive hearing loss. Braz J Otorhinolaryngol 80(2):99–104PubMedCrossRefPubMedCentralGoogle Scholar
  17. Bamiou DE, MacArdle B, Bitner-Glindzicz M et al (2000) Aetiological investigations of hearing loss in childhood. A review (98 references). Clin Otolaryngol Allied Sci 25(2):98–106PubMedCrossRefPubMedCentralGoogle Scholar
  18. Bamiou DE, Davies R, Jones S et al (2004) An unusual case of X-linked adrenoleukodystrophy with auditory processing difficulties as the first and sole clinical manifestation. J Am Acad Audiol 15(2):152–160PubMedCrossRefPubMedCentralGoogle Scholar
  19. Bamiou DE, Campbell NG, Musiek FE et al (2007) Auditory and verbal working memory deficits in a child with congenital aniridia due to a PAX6 mutation. Int J Audiol 46(4):196–202PubMedCrossRefPubMedCentralGoogle Scholar
  20. Bausch A (2016) Strekin AG announces the presentation of key STR001 data at the conference on molecular biology of hearing and deafness, Cambridge UK. Available via http://www.prnewswire.com/news-releases/strekin-ag-announces-the-presentation-of-key-str001-data-at-the-conference-on-molecular-biology-of-hearing-and-deafness-cambridge-uk-585189461.html. Accessed 15 Apr 2017
  21. Baylancicek S, Serin GM, Ciprut A et al (2008) Ototoxic effect of topical ciclopirox as an antimycotic preparation. Otol Neurotol 29(7):910–913PubMedCrossRefPubMedCentralGoogle Scholar
  22. Beahan N, Kei J, Driscoll C et al (2012) High-frequency pure-tone audiometry in children: a test-retest reliability study relative to ototoxic criteria. Ear Hear 33(1):104–111PubMedCrossRefPubMedCentralGoogle Scholar
  23. Berg KM, Smith MC (1983) Behavioral thresholds for tones during infancy. J Exp Child Psychol 35(3):409–425PubMedCrossRefPubMedCentralGoogle Scholar
  24. Bergamaschi C, Bergonzoni L, Mazzanti E et al (2008) Hearing loss in Turner syndrome: results of a multicentric study. J Endocrinol Invest 31(9):779–783PubMedCrossRefPubMedCentralGoogle Scholar
  25. Berglin CE, Pierre PV, Bramer T et al (2011) Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model. Cancer Chemother Pharmacol 68(6):1547–1556PubMedCrossRefPubMedCentralGoogle Scholar
  26. Berlucchi M, Soresina A, Redaelli De Zinis LO et al (2008) Sensorineural hearing loss in primary antibody deficiency disorders. J Pediatr 153(2):293–296PubMedCrossRefPubMedCentralGoogle Scholar
  27. Bess FH, Tharpe AM, Gibler AM (1986) Auditory performance of children with unilateral sensorineural hearing loss. Ear Hear 7(1):20–26PubMedCrossRefPubMedCentralGoogle Scholar
  28. Bess FH, Dodd-Murphy J, Parker RA (1998) Children with minimal sensorineural hearing loss: prevalence, educational performance, and functional status. Ear Hear 19(5):339–354PubMedCrossRefPubMedCentralGoogle Scholar
  29. Bilavsky E, Shahar-Nissan K, Pardo J et al (2016) Hearing outcome of infants with congenital cytomegalovirus and hearing impairment. Arch Dis Child 101(5):433–438PubMedCrossRefPubMedCentralGoogle Scholar
  30. Bitner-Glindzicz M, Rahman S (2007) Ototoxicity caused by aminoglycosides. BMJ 335(7624):784–785PubMedPubMedCentralCrossRefGoogle Scholar
  31. Bochennek K, Allwinn R, Langer R et al (2014) Differential loss of humoral immunity against measles, mumps, rubella and varicella-zoster virus in children treated for cancer. Vaccine 32(27):3357–3361PubMedCrossRefPubMedCentralGoogle Scholar
  32. Bogazzi F, Russo D, Raggi F et al (2004) Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct. J Endocrinol Invest 27(5):430–435PubMedCrossRefPubMedCentralGoogle Scholar
  33. Bogovic P, Strle F (2015) Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management. World J Clin Cases 3(5):430–441PubMedPubMedCentralCrossRefGoogle Scholar
  34. Boppana SB, Ross SA, Novak Z et al (2010) Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 303(14):1375–1382PubMedPubMedCentralCrossRefGoogle Scholar
  35. Bortoli R, Santiago M (2007) Chloroquine ototoxicity. Clin Rheumatol 26(11):1809–1810PubMedCrossRefPubMedCentralGoogle Scholar
  36. Briscoe J, Bishop DV, Norbury CF (2001) Phonological processing, language, and literacy: a comparison of children with mild-to-moderate sensorineural hearing loss and those with specific language impairment. J Child Psychol Psychiatry 42(3):329–340PubMedCrossRefPubMedCentralGoogle Scholar
  37. Brock PR, Knight KR, Freyer DR et al (2012) Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J Clin Oncol 30(19):2408–2417PubMedPubMedCentralCrossRefGoogle Scholar
  38. Brock PR, Maibach R, Childs M et al (2018) Sodium thiosulfate for protection from cisplatin-induced hearing loss. N Engl J Med 378(25):2376–2385PubMedPubMedCentralCrossRefGoogle Scholar
  39. Brown ZA, Wald A, Morrow RA et al (2003) Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289(2):203–209PubMedCrossRefPubMedCentralGoogle Scholar
  40. Buhrman D, Thakkar K, Poe M et al (2013) Natural history of Sanfilippo syndrome type A. J Inherit Metab Dis 37(3):431–437.  https://doi.org/10.1007/s10545-013-9661-8CrossRefPubMedPubMedCentralGoogle Scholar
  41. Candamourty R, Venkatachalam S, Yuvaraj V et al (2013) Cleidocranial dysplasia with hearing loss. J Nat Sci Biol Med 4(1):245–249.  https://doi.org/10.4103/0976-9668.107318CrossRefPubMedPubMedCentralGoogle Scholar
  42. Carney AE, Moeller MP (1998) Treatment efficacy: hearing loss in children. J Speech Lang Hear Res 41(1):S61–S84PubMedPubMedCentralGoogle Scholar
  43. Caserta MT, Hall CB, Canfield RL et al (2014) Early developmental outcomes of children with congenital HHV-6 infection. Pediatrics 134(6):1111–1118PubMedPubMedCentralCrossRefGoogle Scholar
  44. Center for Early Intervention on Deafness (2016) Stages of early development: birth through three years of age. Available via http://ceid.org/wp-content/uploads/2014/06/Stages_of_auditory_development.pdf. Accessed 14 July 2017
  45. Centers for Disease Control and Prevention (2016) Learn the signs: developmental milestones. Available via https://www.cdc.gov/ncbddd/actearly/milestones/index.html. Accessed 14 July 2017
  46. Chang KW, Chinosornvatana N (2010) Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol 28(10):1788–1795PubMedCrossRefPubMedCentralGoogle Scholar
  47. Chao CK, Czechowicz JA, Messner AH et al (2012) High prevalence of hearing impairment in HIV-infected peruvian children. Otolaryngol Head Neck Surg 146(2):259–265PubMedCrossRefPubMedCentralGoogle Scholar
  48. Chen JN, Ho KY, Juan KH (1998) Sensorineural hearing loss in MELAS syndrome—case report. Kaohsiung J Med Sci 14(8):519–523PubMedPubMedCentralGoogle Scholar
  49. Chen YN, Liou CW, Huang CC et al (2004) Maternally inherited diabetes and deafness (MIDD) syndrome: a clinical and molecular genetic study of a Taiwanese family. Chang Gung Med J 27(1):66–73PubMedPubMedCentralGoogle Scholar
  50. Chetcuti K, Abernethy LJ, Bruce C (2014) An 8-year-old girl with congenital deafness and musculoskeletal abnormalities. Arch Dis Child 99(7):665.  https://doi.org/10.1136/archdischild-2013-305836CrossRefPubMedPubMedCentralGoogle Scholar
  51. Chien W, Leiding JW, Hsu AP et al (2014) Auditory and vestibular phenotypes associated with GATA3 mutation. Otol Neurotol 35(4):577–581.  https://doi.org/10.1097/MAO.0000000000000238CrossRefPubMedPubMedCentralGoogle Scholar
  52. Choo D, Meinzen-Derr J (2010) Universal newborn hearing screening in 2010. Curr Opin Otolaryngol Head Neck Surg 18(5):399–404.  https://doi.org/10.1097/MOO.0b013e32833d475dCrossRefPubMedPubMedCentralGoogle Scholar
  53. Çiftdoğan DY, Vardar F (2011) Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection. J Trop Pediatr 57(2):132–134CrossRefGoogle Scholar
  54. Cohen BE, Durstenfeld A, Roehm PC (2014) Viral causes of hearing loss: a review for hearing health professionals. Trends Hear 18:1–17Google Scholar
  55. Connolly JL, Carron JD, Roark SD (2005) Universal newborn hearing screening: are we achieving the Joint Committee on Infant Hearing (JCIH) objectives? Laryngoscope 115(2):232–236PubMedCrossRefPubMedCentralGoogle Scholar
  56. Cook C (2007) Cytomegalovirus reactivation in “immunocompetent” patients: a call for scientific prophylaxis. J Infect Dis 196(9):1273–1275PubMedCrossRefPubMedCentralGoogle Scholar
  57. Cook CJ, Williams C, Gluckman PD (1987) Brainstem auditory evoked potentials in the fetal sheep, in utero. J Dev Physiol 9(5):429–439PubMedPubMedCentralGoogle Scholar
  58. Cordier AG, Guitton S, Vauloup-Fellous C et al (2012a) Awareness of cytomegalovirus infection among pregnant women in France. J Clin Virol 53(4):332–337PubMedCrossRefPubMedCentralGoogle Scholar
  59. Cordier AG, Guitton S, Vauloup-Fellous C et al (2012b) Awareness and knowledge of congenital cytomegalovirus infection among health care providers in France. J Clin Virol 55(2):158–163PubMedCrossRefPubMedCentralGoogle Scholar
  60. Costa OA, Axelsson A, Aniansson G (1988) Hearing loss at age 7, 10 and 13—an audiometric follow-up study. Scand Audiol Suppl 30:25–32PubMedPubMedCentralGoogle Scholar
  61. Crowson M, Schulz K, Tucci D (2016) National utilization and forecasting of ototopical antibiotics: Medicaid Data versus “Dr. Google”. Otol Neurotol 37(8):1049–1054PubMedCrossRefPubMedCentralGoogle Scholar
  62. Cupples L, Ching TYC, Crowe K et al (2014) Outcomes of 3-year-old children with hearing loss and different types of additional disabilities. Deaf Stud Deaf Educ 19(1):20–39CrossRefGoogle Scholar
  63. da Silva Araújo E, Zucki F, Corteletti LCBJ et al (2012) Hearing loss and acquired immune deficiency syndrome: systematic review. J Soc Bras Fonoaudiol 24(2):188–192CrossRefGoogle Scholar
  64. Dahle AJ, Fowler KB, Wright JD et al (2000) Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 11(5):283–290PubMedPubMedCentralGoogle Scholar
  65. Davis A, Wood S (1992) The epidemiology of childhood hearing impairment: factor relevant to planning of services. Brit J Audiol 26(2):77–90CrossRefGoogle Scholar
  66. Davis A, Mencher G, Moorjani P (2004) An epidemiological perspective on childhood hearing impairment. In: McCormick B (ed) Paediatric audiology 0-5 years, 3rd edn. Whurr Publishers, London, pp 1–40Google Scholar
  67. de Hoog M, van Zanten BA, Hop WC et al (2003) Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss. J Pediatr 142(1):41–46PubMedCrossRefPubMedCentralGoogle Scholar
  68. de Vries JJ, Barbi M, Binda S et al (2012) Extraction of DNA from dried blood in the diagnosis of congenital CMV infection. Methods Mol Biol 903:169–175PubMedCrossRefPubMedCentralGoogle Scholar
  69. DeCasper AJ, Fifer WP (1980) Of human bonding: newborns prefer their mothers’ voices. Science 208(4448):1174–1176PubMedCrossRefPubMedCentralGoogle Scholar
  70. Dewan P, Gupta P (2012) Burden of congenital Rubella syndrome (CRS) in India: a systematic review. Indian Pediatr 49(5):377–399PubMedCrossRefPubMedCentralGoogle Scholar
  71. Dobie RA, Van Hemel S (2004) Hearing loss: determining eligibility for social security benefits, Chapter 7 hearing loss in children. National Academies Press, Washington, DC, p 180–223. Available via https://www.ncbi.nlm.nih.gov/books/NBK207837/. Accessed 12 Feb 2017
  72. Dockum GD, Robinson DO (1975) Warble tone as an audiometric stimulus. J Speech Hear Disord 40(3):351–356PubMedCrossRefPubMedCentralGoogle Scholar
  73. Dreisbach L, Zettner E, Chang LM et al (2018) High-frequency distortion-product otoacoustic emission repeatability in a patient population. Ear Hear 39(1):85–100PubMedCrossRefPubMedCentralGoogle Scholar
  74. Eagles EL, Wishik SM, Doerfler LG et al (1963) Hearing sensitivity and related factors in children. University of Pittsburgh, Graduate School of Public Health, Pittsburgh, 1st edn. Laryngoscope, St. LouisGoogle Scholar
  75. Eggermont JJ, Salamy A (1988) Maturational time course for the ABR in preterm and full term infants. Hear Res 33(1):35–47PubMedCrossRefPubMedCentralGoogle Scholar
  76. Eisenberg LS (2007) Current state of knowledge: speech recognition and production in children with hearing impairment. Ear Hear 28(6):766–772PubMedCrossRefPubMedCentralGoogle Scholar
  77. El-Badry MM, Abousetta A, Kader RMA (2015) Vestibular dysfunction in patients with post-mumps sensorineural hearing loss. J Laryngol Otol 129(4):337–341PubMedCrossRefPubMedCentralGoogle Scholar
  78. Encyclopædia Britannica Online (2011) Deafness. Encyclopædia Britannica Inc. Accessed 22 Feb 2012Google Scholar
  79. Enders G, Daiminger A, Bader U et al (2011) Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52(3):244–246PubMedCrossRefPubMedCentralGoogle Scholar
  80. Feder KP, Michaud D, McNamee J et al (2017) Prevalence of hearing loss among a representative sample of Canadian Children and adolescents, 2 to 19 years of age. Ear Hear 38(1):7–20PubMedCrossRefPubMedCentralGoogle Scholar
  81. First Years (2011) Developmental milestones, birth to 8 years. Available via http://firstyears.org/miles/chart.htm. Accessed 14 July 2017
  82. Flipsen P (2008) Intelligibility of spontaneous conversational speech produced by children with cochlear implants: a review. Int J Pediatr Otorhinolaryngol 72(5):559–564PubMedCrossRefPubMedCentralGoogle Scholar
  83. Forsythe E, Beales PL (2015) Bardet-Biedl syndrome. In: Pagon RA et al (ed) GeneReviews® [Internet]. University of Washington, Seattle, SeattleGoogle Scholar
  84. Fortnum H (2003) Epidemiology of permanent childhood hearing impairment: implications for neonatal hearing screening. Audiol Med 1(3):155–164CrossRefGoogle Scholar
  85. Fortnum H, Davis A (1997) Epidemiology of permanent childhood hearing impairment in Trent Region, 1985-1993. Br J Audiol 31(6):409–446. Available via http://www.ncbi.nlm.nih.gov/pubmed/9478287. Accessed 11 May 2018PubMedPubMedCentralCrossRefGoogle Scholar
  86. Fortnum HM, Summerfield AQ, Marshall DH et al (2001) Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study. BMJ 323(7312):536–540.  https://doi.org/10.1136/bmj.323.7312.536CrossRefPubMedPubMedCentralGoogle Scholar
  87. Foulon I, Naessens A, Foulon W et al (2008) A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J Pediatr 153(1):84158CrossRefGoogle Scholar
  88. Fowler KB (2013) Congenital cytomegalovirus infection: audiologic outcome. Clin Infect Dis 57(Suppl 4):S182–S184PubMedPubMedCentralCrossRefGoogle Scholar
  89. Freyer DR, Chen L, Krailo MD et al (2017) Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Oncol 18(1):63–74PubMedCrossRefPubMedCentralGoogle Scholar
  90. Freyer DR, Frazier AL, Sung L (2018) Sodium thiosulfate and cisplatin-induced hearing loss. N Engl J Med 379(12):1180–1181PubMedCrossRefPubMedCentralGoogle Scholar
  91. Furniss F, Biswas AB, Gumber R et al (2011) Cognitive phenotype of velocardiofacial syndrome: a review. Res Dev Disabil 32(6):2206–2213PubMedCrossRefPubMedCentralGoogle Scholar
  92. Geers AE (2006) Factors influencing spoken language outcomes in children following early cochlear implantation. In: Moller AR (ed) Cochlear and brainstem implants. Adv Otorhinolaryngol. Karger, Basel, pp 50–65CrossRefGoogle Scholar
  93. Genetic Testing Registry (2016) Schinzel-Giedion syndrome. Available via https://www.ncbi.nlm.nih.gov/gtr/conditions/C1849294/. Accessed 27 July 2016
  94. Genetics Home Reference (2016a) X-linked agammaglobulinemia. Available via https://ghr.nlm.nih.gov/condition/x-linked-agammaglobulinemia#synonyms. Accessed 4 Sept 2016
  95. Genetics Home Reference (2016b) X-linked adrenoleukodystrophy. Available via https://ghr.nlm.nih.gov/condition/x-linked-adrenoleukodystrophy. Accessed 4 Sept 2016
  96. Genetics Home Reference (2016c) Oculodentodigital dysplasia. Available via https://ghr.nlm.nih.gov/condition/oculodentodigital-dysplasia#definition. Accessed 30 July 2016
  97. Genetics Home Reference (2016d) Mucopolysaccharidosis type III. Available via https://ghr.nlm.nih.gov/condition/mucopolysaccharidosis-type-iii. Accessed 31 July 2016
  98. Goderis J, De Leenheer E, Smets K et al (2014) Hearing loss and congenital CMV infection: a systematic review. Pediatrics 134(5):972–982PubMedCrossRefPubMedCentralGoogle Scholar
  99. Goodman S (2011) Comparison of high-frequency TEOAEs and DPOAEs for monitoring ototoxicity in pediatric cancer patients. Lecture presented at Illinois Speech-Language-Hearing Association 2011. Available via https://clas.uiowa.edu/sites/clas.uiowa.edu.comsci/files/groups/arl/pubs/goodman_isha_2011.pdf. Accessed 21 Jan 2017
  100. Gordon JS, Phillips DS, Helt WJ et al (2005) Evaluation of insert earphones for high-frequency bedside ototoxicity monitoring. J Rehabil Res Dev 42(3):353–361PubMedCrossRefPubMedCentralGoogle Scholar
  101. Gravel JS, Wallace IF (1992) Listening and language at 4 years of age: effects of early otitis media. J Speech Hear Res 35(3):588–595PubMedCrossRefPubMedCentralGoogle Scholar
  102. Greenberg A (2000) Diuretic complications. Am J Med Sci 319(1):10–24PubMedCrossRefPubMedCentralGoogle Scholar
  103. Grosse SD, Rossa DS, Dollard SC (2008) Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol 41(2):57–62PubMedCrossRefPubMedCentralGoogle Scholar
  104. Gürkov R, Eshetu T, Miranda IB et al (2008) Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial. Malar J 7:179PubMedPubMedCentralCrossRefGoogle Scholar
  105. Gurney JG, Bass JK (2012) New International Society of Pediatric Oncology Boston Ototoxicity Grading Scale for pediatric oncology: still room for improvement. J Clin Oncol 30(19):2303–2306PubMedCrossRefPubMedCentralGoogle Scholar
  106. Guy R, Nicholson J, Pannu SS et al (2003) A clinical evaluation of ophthalmic assessment in children with sensorineural deafness. Child Care Health Dev 29(5):377–384PubMedCrossRefPubMedCentralGoogle Scholar
  107. Haapala S, Niemitalo-Haapola E, Raappana A et al (2015) Long-term influence of recurrent acute otitis media on neural involuntary attention switching in 2-year-old children. Behav Brain Funct 12:1CrossRefGoogle Scholar
  108. Haapaniemi JJ (1996) The hearing threshold levels of children at school age. Ear Hear 17(6):469–477PubMedCrossRefPubMedCentralGoogle Scholar
  109. Hall C, Caserta M, Schnabel K et al (2010) Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus. J Infect Dis 201(4):505–507.  https://doi.org/10.1086/650495CrossRefPubMedPubMedCentralGoogle Scholar
  110. Hall JW III (2013) Should Tone Burst ABR be Performed at 8000 Hz for Infant Hearing Assessment? https://www.audiologyonline.com/ask-the-experts/should-tone-burst-abr-performed-11941. Accessed 25 April 2019
  111. Hamdan HZ, Abdelbagi IE, Nasser NM et al (2011) Seroprevalence of cytomegalovirus and rubella among pregnant women in western Sudan. Virol J 8:217PubMedPubMedCentralCrossRefGoogle Scholar
  112. Harris JP, Woolf NK, Ryan AF et al (1984) Immunologic and electrophysiological response to cytomegaloviral inner ear infection in the guinea pig. J Infect Dis 150(4):523–530PubMedCrossRefPubMedCentralGoogle Scholar
  113. Harris T, Peer S, Fagan JJ (2012) Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting. J Laryngol Otol 126(6):548–551CrossRefGoogle Scholar
  114. Haynes DS, Rutka J, Hawke M et al (2007) Ototoxicity of ototopical drops—an update. Otolaryngol Clin North Am 40(3):669–683PubMedCrossRefPubMedCentralGoogle Scholar
  115. Hepper PG, Shahidullah BS (1994) Development of fetal hearing. Arch Dis Child Fetal Neonatal Ed 71(2):F81–F87PubMedPubMedCentralCrossRefGoogle Scholar
  116. Hereditary Hearing Loss Homepage (2016) Mitochondrial mutations associated with syndromic hearing impairment. Available via http://hereditaryhearingloss.org/main.aspx?c=.HHH&n=86517&ct=78933&e=234541. Accessed 2 Aug 2016
  117. Holmes AE, Niskar AS, Kieszak SM et al (2004) Mean and median hearing thresholds among children 6 to 19 years of age: the Third National Health And Nutrition Examination Survey, 1988 to 1994, United States. Ear Hear 25(4):397–402PubMedCrossRefPubMedCentralGoogle Scholar
  118. Hong D, Kent JS, Kesler S (2009) Cognitive profile of Turner syndrome. Dev Disabil Res Rev 15(4):270–278.  https://doi.org/10.1002/ddrr.79CrossRefPubMedPubMedCentralGoogle Scholar
  119. Hotta H (1997) Neurotropic viruses: classification, structure and characteristics. Nihon Rinsho 55(4):777–782PubMedPubMedCentralGoogle Scholar
  120. Hoversten GH, Moncur JP (1969) Stimuli and intensity factors in testing infants. J Speech Hear Res 12(4):677–686CrossRefGoogle Scholar
  121. Hrapcak S, Kuper H, Bartlett P et al (2016) Hearing loss in HIV-infected children in Lilongwe, Malawi. PLoS One 11(8):e0161421.  https://doi.org/10.1371/journal.pone.0161421. Accessed 8 Jan 2017CrossRefPubMedPubMedCentralGoogle Scholar
  122. International Organization for Standardization (2010) 8253-1: Acoustics—audiometric test methods, part 1: pure tone air and bone conduction audiometry. Available via https://www.iso.org/standard/43601.html. Accessed 2 Apr 2017
  123. International Osteoporosis Foundation (IOF) (2015) Camurati-Engelmanndiseasetype 2. Available via https://www.iofbonehealth.org/osteoporosis-musculoskeletal-disorders/skeletal-rare-disorders/camurati-engelmann-disease-type-2. Accessed 6 Mar 2017
  124. Jackson AC (ed) (2013) Viral infections of the human nervous system. Springer, BaselGoogle Scholar
  125. Jacobs P, Silaski G, Wilmington D et al (2012) Development and evaluation of a portable audiometer for high frequency screening of hearing loss from ototoxicity in homes/clinics. IEEE Trans Biomed Eng 59(11):3097–3103PubMedCrossRefPubMedCentralGoogle Scholar
  126. Ječmenica JR, Opančina AAB (2015) Characteristics of brain stem auditory evoked potentials in children with hearing impairment due to infectious diseases. J Child Neurol 30(6):683–689PubMedCrossRefPubMedCentralGoogle Scholar
  127. Jehanne M, Lumbroso-Le Rouic L, Savignoni A et al (2009a) Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma. Pediatr Blood Cancer 52(5):637–643PubMedCrossRefPubMedCentralGoogle Scholar
  128. Jehanne M, Mercier G, Doz F (2009b) Monitoring of ototoxicity in young children receiving carboplatin for retinoblastoma. Pediatr Blood Cancer 53(6):1162PubMedCrossRefPubMedCentralGoogle Scholar
  129. Jerger S, Lai L, Marchman VA (2002) Picture naming by children with hearing loss: I. Effect of semantically related auditory distracters. J Am Acad Audiol 13(9):463–477PubMedPubMedCentralGoogle Scholar
  130. Joint Committee on Infant Hearing (2007) Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 120(4):898–921CrossRefGoogle Scholar
  131. Kadambari S, Luck S, Davis A et al (2013) Clinically targeted screening for congenital CMV—potential for integration into the National Hearing Screening Programme. Acta Paediatr 102(10):928–933PubMedCrossRefPubMedCentralGoogle Scholar
  132. Kadambari S, Luck S, Davis A et al (2015a) Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK. Eur J Pediatr 174(8):1117–1121PubMedCrossRefPubMedCentralGoogle Scholar
  133. Kadambari S, Walter S, Stimson L et al (2015b) Integration rapid diagnostic testing for congenital CMV into the Newborn Hearing Screening Programme: the audiovestibular physician’s perspective. Arch Dis Child Fetal Neonatal Ed 100(5):F466–F467.  https://doi.org/10.1136/archdischild-2015-308884CrossRefPubMedPubMedCentralGoogle Scholar
  134. Kaiser R (2012) Tick-borne encephalitis: clinical findings and prognosis in adults. Wien Med Wochenschr 162(11–12):239–243PubMedCrossRefPubMedCentralGoogle Scholar
  135. Kariya S, Schachern PA, Nishizaki K et al (2012) Inner ear changes in mucopolysaccharidosis type I/Hurler syndrome. Otol Neurotol 33(8):1323–1327.  https://doi.org/10.1097/MAO.0b013e3182659cc3CrossRefPubMedPubMedCentralGoogle Scholar
  136. Karma P, Sipila M, Rahko T (1989) Hearing and hearing loss in 5-year-old children. Pure-tone thresholds and the effect of acute otitis media. Scand Audiol 18(4):199–203PubMedCrossRefPubMedCentralGoogle Scholar
  137. Keefe DH, Goodman SS, Ellison JC et al (2011) Detecting high-frequency hearing loss with click-evoked otoacoustic emissions. J Acoust Soc Am 129(1):245–261PubMedPubMedCentralCrossRefGoogle Scholar
  138. Keilmann A, Nakarat T, Bruce IA et al (2012) Hearing loss in patients with mucopolysaccharidosis II: data from HOS—the Hunter Outcome Survey. J Inherit Metab Dis 35(2):343–353.  https://doi.org/10.1007/s10545-011-9378-5CrossRefPubMedPubMedCentralGoogle Scholar
  139. Keupp K, Li Y, Vargel I et al (2013) Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis. Mol Genet Genomic Med 1(4):223–237.  https://doi.org/10.1002/mgg3.28CrossRefPubMedPubMedCentralGoogle Scholar
  140. Kimberlin DW (2004) Neonatal herpes simplex infection. Clin Microbiol Rev 17(1):1–13PubMedPubMedCentralCrossRefGoogle Scholar
  141. Kimberlin DW, Lin CY, Sánchez PJ et al (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143(1):16–25PubMedCrossRefPubMedCentralGoogle Scholar
  142. Kimberlin DW, Jester PM, Sanchez PJ et al (2015) Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 372(10):933–943PubMedPubMedCentralCrossRefGoogle Scholar
  143. Klausen O, Moller P, Holjefjord A et al (2007) Lasting effects of otitis media with effusion on language skills and listening performance. Acta Otolaryngol Suppl 543:73–76Google Scholar
  144. Knight KR, Kraemer DF, Neuwelt EA (2005) Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 23(34):8588–8596PubMedCrossRefPubMedCentralGoogle Scholar
  145. Knight KR, Kraemer DF, Winter C et al (2007) Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol 25(10):1190–1195PubMedCrossRefPubMedCentralGoogle Scholar
  146. Knight K, Chen L, Freyer D et al (2016) Group-wide, prospective study of ototoxicity assessment in children receiving cisplatin chemotherapy (ACCL05C1): a report from the Children’s Oncology Group. J Clin Oncol 2016:JCO2016692319. Epub ahead of print
  147. Koo J-W, Quintanilla-Dieck L, Jiang M et al (2015) Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity. Sci Transl Med 7(298):298ra118.  https://doi.org/10.1126/scitranslmed.aac5546CrossRefPubMedPubMedCentralGoogle Scholar
  148. Koontz D, Baecher K, Amin M et al (2015) Evaluation of DNA extraction methods for the detection of cytomegalovirus in dried blood spots. J Clin Virol 66:95–99PubMedPubMedCentralCrossRefGoogle Scholar
  149. Kozlova SN, Demikova NS, Seemanova E et al (1996) Nasledstvennie sindromy i mediko-genetičeckoe konsultirovanie [Inherited syndromes and medical—genetic consultancy]. Praktika, Moscow, p 470Google Scholar
  150. Kranzer K, Elamin WF, Cox H et al (2015) A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB. Thorax 70:1070–1077PubMedCrossRefPubMedCentralGoogle Scholar
  151. Kuhl PK, Meltzoff AN (1996) Infant vocalizations in response to speech: vocal imitation and developmental change. J Acoust Soc Am 100(4 pt 1):2425–2438PubMedPubMedCentralCrossRefGoogle Scholar
  152. Kuriger M, Lesimple C (2012) Frequency Composition™: a new approach to frequency lowering. Available via http://prof.bernafon.ca/downloads/~/media/pdf/english/global/bernafon/whitepaper/bf_wp_frequency_composition_uk.ashx. Accessed 29 Apr 2017
  153. Lackner A, Acham A, Alborno T et al (2009) Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up. J Laryngol Otol 123(4):391–396PubMedCrossRefPubMedCentralGoogle Scholar
  154. Lafay-Cousin L, Purdy E, Huang A et al (2013) Early cisplatin ototoxicity profile may predict the need for hearing support in children with medulloblastoma. Pediatr Blood Cancer 60(2):287–292PubMedCrossRefPubMedCentralGoogle Scholar
  155. Laffan C (1993) Vision in communication. Talking Sense 39(4)Google Scholar
  156. Landier W, Knight K, Wong FL et al (2014) Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales—a report from the Children’s Oncology Group. J Clin Oncol 32(6):527–534PubMedPubMedCentralCrossRefGoogle Scholar
  157. Langer T, am Zehnhoff-Dinnesen A, Radtke S et al (2013) Understanding platinum-induced ototoxicity. Trends Pharmacol Sci 34(8):458–469PubMedCrossRefPubMedCentralGoogle Scholar
  158. Laughton B, Cornell M, Boivin M et al (2013) Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J Int AIDS Soc 16(1):18603PubMedPubMedCentralCrossRefGoogle Scholar
  159. Levine D, Strother-Garcia K, Golinkoff R et al (2016) Language development in the first year of life: what deaf children might me missing before cochlear implantation. Otol Neurotol 37(2):e56–e62.  https://doi.org/10.1097/MAO.0000000000000908. Nashville CI PapersCrossRefPubMedPubMedCentralGoogle Scholar
  160. Lewis S, Moralee M, Skipp A et al (2006) The Early Support Monitoring protocol for deaf babies and children. Available via DfES Publications. http://www.batod.org.uk/content/resources/nhsp/useMP.pdf. Accessed 3 Apr 2016
  161. Liden G, Kankkunen A (1969) Visual reinforcement audiometry. Acta Otolaryngol 67(2):281–292PubMedCrossRefPubMedCentralGoogle Scholar
  162. Luck SE, Wieringa JW, Blázques-Gamero D et al (2017) Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management. Pediatr Infect Dis J 36(12):1205–1213PubMedCrossRefPubMedCentralGoogle Scholar
  163. Makar SK, Dhara S, Sinha AK et al (2012) Nature and onset of communication disorder in pediatrics with HIV. Int J Pediatr Otorhinolaryngol 76(7):1065–1066PubMedCrossRefPubMedCentralGoogle Scholar
  164. MalaCards: The human disease database (2016) Cleidocranial dysplasia recessive form. Available via http://www.malacards.org/card/cleidocranial_dysplasia_recessive_form#related_genes. Accessed 31 July 2016
  165. Mansour SL, Twigg SRF, Freeland RM et al (2009) Hearing loss in a mouse model of Muenke syndrome. Hum Mol Genet 18(1):43–50.  https://doi.org/10.1093/hmg/ddn311CrossRefPubMedPubMedCentralGoogle Scholar
  166. Marsala SZ, Pistacchi M, Gioulis M et al (2014) Neurological complications of tick borne encephalitis: the experience of 89 patients studied and literature review. Neurol Sci 35(1):15–21CrossRefGoogle Scholar
  167. Mathers C, Smith A, Concha M (2003) Global burden of hearing loss in the year 2000 (2003). Global Burden of Disease World Health Organization, Geneva, pp 1–30. Available via http://www.who.int/healthinfo/statistics/bod_hearingloss.pdf. Accessed 2 Nov 2016Google Scholar
  168. Maw JL, Kartush JM, Bouchard K et al (2000) Octylcyanoacrylate: a new medical-grade adhesive for otologic surgery. Am J Otol 21(3):310–314PubMedCrossRefPubMedCentralGoogle Scholar
  169. McArthur G, Kohnen S, Larsen L et al (2013) Getting to grips with the heterogeneity of developmental dyslexia. Cogn Neuropsychol 30(1):1–24PubMedCrossRefPubMedCentralGoogle Scholar
  170. McDermott JC, Hodgson WR (1982) Auditory thresholds in children for narrow-band noise and warble tones in sound field. Brit J Audiol 16(4):221–225CrossRefGoogle Scholar
  171. McKenna MJ (1997) Measles, mumps, and sensorineural hearing loss. Ann N Y Acad Sci 830:291–298PubMedCrossRefPubMedCentralGoogle Scholar
  172. McLean HQ, Fiebelkorn AP, Temte JL et al (2013) Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62(42013):1–34PubMedPubMedCentralGoogle Scholar
  173. Medscape (2016) Fetal alcohol syndrome. Available via http://emedicine.medscape.com/article/974016-overview. Accessed 3 June 2017
  174. Mercy Clinic Kids Plastic Surgery (2016) Muenke syndrome treatment. Available via https://www.mercy.net/practice/mercy-clinic-kids-plastic-surgery/muenke-syndrome-treatment. Accessed 30 July 2016
  175. Milunsky JM (2001) Waardenburg syndrome type I. In: Pagon RA et al (eds) Gene reviews. University of Washington, SeattleGoogle Scholar
  176. Mitchell CR, Ellingson RM, Henry JA et al (2004) Use of auditory brainstem responses for the early detection of ototoxicity from aminoglycosides or chemotherapeutic drugs. J Rehabil Res Dev 41(3A):373–382PubMedCrossRefPubMedCentralGoogle Scholar
  177. Moller C (2002) Balance disorders. In: Newton VE (ed) Paediatric audiological medicine. Whurr Publishers, LondonGoogle Scholar
  178. Möller S, Schönweiler R (1999) Analysis of infant cries for the early detection of hearing impairment. Speech Comm 28(3):175–193CrossRefGoogle Scholar
  179. Monasta L, Ronfani L, Marchetti F et al (2012) Burden of disease caused by otitis media: systematic review and global estimates. PLoS One 7(4):e36226PubMedPubMedCentralCrossRefGoogle Scholar
  180. Moore K, Violetto D (2016) FRESH noise—a fresh approach to pediatric testing. AudiologyOnline, Article 17035. Available via http://www.audiologyonline.com/articles/fresh-noise-approach-to-pediatric-17035. Accessed 3 Apr 2017
  181. Moore JM, Wilson W (1978) Visual reinforcement audiometry (VRA) with infants. In: Gerber SE et al (eds) Early diagnosis of hearing loss. Grune & Stretten, New YorkGoogle Scholar
  182. Morgan G (2014) On language acquisition in speech and sign: development of combinatorial structure in both modalities. Front Psychol 5:1217PubMedPubMedCentralCrossRefGoogle Scholar
  183. Morton NE (1991) Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 630:16–31PubMedCrossRefPubMedCentralGoogle Scholar
  184. Morton CC, Nance WE (2006) Newborn hearing screening—a silent revolution. N Engl J Med 354(20):2151–2164.  https://doi.org/10.1056/NEJMra050700CrossRefGoogle Scholar
  185. Mudd PA, Edmunds AL, Glatz FR et al (2012) Ototoxicity. Medscape. Available via http://emedicine.medscape.com/article/857679-overview. Accessed 9 Sept 2016
  186. Muller WJ, Jones CA, Koelle DM (2010) Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn. Curr Immunol Rev 6(1):38–55PubMedPubMedCentralCrossRefGoogle Scholar
  187. Muscat M, Zimmerman L, Bacci S et al (2012) Toward rubella elimination in Europe: an epidemiological assessment. Vaccine 30(11):1999–2007PubMedCrossRefPubMedCentralGoogle Scholar
  188. Natale V, Raquer H (2017) Xeroderma pigmentosum-Cockayne syndrome complex. Orphanet J Rare Dis 12(1):65PubMedPubMedCentralCrossRefGoogle Scholar
  189. Nath A, Berger JR (2003) Clinical neurovirology: neurological disease and therapy. CRC Press, Boca RatonCrossRefGoogle Scholar
  190. National Institutes of Health (1993) Early identification of hearing impairment in infants and young children. NIH Consensus Statement Online 1993. 11(1):1–24. Available via https://consensus.nih.gov/1993/1993hearinginfantschildren092html.htm. Accessed 5 May 2017
  191. National Institutes of Health NIH, National Cancer Institute NCI (2010) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Available via http://evs.nci.nih.gov/ftp1/CTCAE/About.html. Accessed 5 June 2014
  192. National Organization for Rare Disorders (1993) Fetal hydantoin syndrome. Available via https://rarediseases.org/rare-diseases/fetal-hydantoin-syndrome/. Accessed 3 June 2017
  193. National Organization for Rare Disorders (2005) Trichorhinophalangeal syndrome type II. Available via http://rarediseases.org/rare-diseases/trichorhinophalangeal-syndrome-type-ii/. Accessed 27 July 2016
  194. National Organization for Rare Disorders (2014) Maroteaux Lamy syndrome. Available via http://rarediseases.org/rare-diseases/maroteaux-lamy-syndrome/. Accessed 1 Aug 2016
  195. National Organization for Rare Disorders (2015) Marshall syndrome. Available via https://rarediseases.org/rare-diseases/marshall-syndrome/. Accessed 28 July 2016
  196. NDCS and Sense (2014) Vision care for your deaf child. Available via https://www.sense.org.uk/sites/default/files/Vision_care_for_your_deaf_child_v2.pdf. Accessed 16 May 2016
  197. Ndoleriire C, Turitwenka E, Bakeera-Kitaaka S et al (2013) The prevalence of hearing impairment in the 6 months – 5 years HIV/AIDS-positive patients attending paediatric infectious disease clinic at Mulago Hospital. Int J Pediatr Otorhinolaryngol 77(2):262–265CrossRefGoogle Scholar
  198. Newton VE (1985) Aetiology of bilateral sensori-neural hearing loss in young children. J Laryngol Otol Suppl 10:1–57PubMedPubMedCentralGoogle Scholar
  199. Newton EN, Vallely PJ (eds) (2006) Infection and hearing impairment. Whurr, ChichesterGoogle Scholar
  200. Niedermeyer HP, Arnold W (2008) Otosclerosis and measles virus—association or causation? ORL J Otorhinolaryngol Relat Spec 70(1):63–69PubMedCrossRefPubMedCentralGoogle Scholar
  201. Nigro G, Adler SP, La Torre R et al (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353(13):1350–1362PubMedCrossRefPubMedCentralGoogle Scholar
  202. Nikkel SM, Hunter AG (2013) Normal intelligence and features of Bardet-Biedl syndrome in a family with a duplication of chromosome 20p13-p12.1. Genetics, Children’s Hospital of Eastern Ontario, Ottawa, ON, Canada. Available via www.ashg.org/2013meeting/abstracts/fulltext/f130120786.htm. Accessed 2 Aug 2016
  203. Nikolopoulos TP (2014) Auditory dyssynchrony or auditory neuropathy: understanding the pathophysiology and exploring methods of treatment. Int J Pediatr Otorhinolaryngol 78(2):171–173PubMedCrossRefPubMedCentralGoogle Scholar
  204. Nittrouer S, Sansom E, Low K et al (2014) Language structures used by kindergartners with cochlear implants: relationship to phonological awareness, lexical knowledge and hearing loss. Ear Hear 35(5):506–518PubMedPubMedCentralCrossRefGoogle Scholar
  205. Noorbakhsh S, Farhadi M, Daneshi A et al (2011) Viral infections detected by serology and PCR of perilymphatic fluid in children with idiopathic sensorineural hearing loss. World Health Organization Institutional Repository for Information Sharing. Available via http://apps.who.int/iris/bitstream/10665/118200/1/17_11_2011_0868_0871.pdf?ua=1. Accessed 31 Dec 2016
  206. Northern JL, Downs MP (2014) Hearing in children, 6th edn. Plural Publishing Inc, San DiegoGoogle Scholar
  207. Nozza RJ (1995) Estimating the contribution of non-sensory factors to infant-adult differences in behavioral thresholds. Hear Res 91(1–2):72–78PubMedCrossRefPubMedCentralGoogle Scholar
  208. Nozza RJ, Wilson WR (1984) Masked and unmasked pure-tone thresholds of infants and adults: development of auditory frequency selectivity and sensitivity. J Speech Hear Res 27(4):613–622PubMedCrossRefPubMedCentralGoogle Scholar
  209. O’Hare A, Bremner L (2015) Management of developmental speech and language disorders. Arch Dis Child 101:272–277.  https://doi.org/10.1136/archdischild-2014-307394CrossRefPubMedPubMedCentralGoogle Scholar
  210. Oliver SE, Cloud GA, Sánchez PJ et al (2009) Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 46(4):S22–S26PubMedPubMedCentralCrossRefGoogle Scholar
  211. Olsho LW, Koch EG, Carter EA et al (1988) Pure-tone sensitivity of human infants. J Acoust Soc Am 84(4):1316–1324PubMedCrossRefPubMedCentralGoogle Scholar
  212. Olusanya BO, Neumann KJ, Saunders JE (2014) The global burden of disabling hearing impairment: a call to action. Bull World Health Organ 92(5):367–373PubMedPubMedCentralCrossRefGoogle Scholar
  213. OMIM (2000) Turner syndrome-associated neurocognitive phenotype. Available via https://www.omim.org/entry/313000?search=turner%20syndrome%20patients&highlight=syndromic%20turner%20patient%20syndrome. Accessed 23 Mar 2017
  214. OMIM (2002a) Camurati-Engelmann disease, type 2. Available via https://www.omim.org/entry/606631. Accessed 3 June 2017
  215. OMIM (2002b) Scheie syndrome. Available via https://www.omim.org/entry/607016. Accessed 23 May 2017
  216. OMIM (2005) Cognitive function 1, social; CGF1. Available via https://www.omim.org/entry/300082. Accessed 3 June 2017
  217. OMIM (2006b) Jervell and Lange-Nielsen syndrome 1. Available via https://www.omim.org/entry/220400. Accessed 23 May 2017
  218. OMIM (2006c) Opitz Gbbb syndrome, type I. Available via https://www.omim.org/entry/300000. Accessed 23 May 2017
  219. OMIM (2007a) Mucopolysaccharidosis, type IVB. Available via https://www.omim.org/entry/253010. Accessed 23 May 2017
  220. OMIM (2007b) FG syndrome 3. Available via https://www.omim.org/entry/300406. Accessed 23 May 2017
  221. OMIM (2008) Crouzon syndrome with acanthosis nigricans. Available via https://www.omim.org/entry/612247. Accessed 3 June 2017
  222. OMIM (2009a) Biotinidase deficiency. Available via https://omim.org/entry/253260. Accessed 23 May 2017
  223. OMIM (2009b) Ciliary dyskinesia, primary, 1, with or without situs inversus. Avalaible via https://www.omim.org/entry/244400. Accessed 3 June 2017
  224. OMIM (2009c) Refsum disease, classic. Available via https://www.omim.org/entry/266500. Accessed 23 May 2017
  225. OMIM (2009d) FG syndrome 2. Available via https://www.omim.org/entry/300321. Accessed 23 May 2017
  226. OMIM (2009e) Otopalatodigital syndrome, type I. Available via https://www.omim.org/entry/311300. Accessed 23 May 2017
  227. OMIM (2010a) Diastrophic dysplasia. Available via https://www.omim.org/entry/222600. Accessed 23 May 2017
  228. OMIM (2010b) Opitz-Kaveggia syndrome. Available via https://www.omim.org/entry/305450. Accessed 23 May 2017
  229. OMIM (2010c) Agammaglobulinemia, X-Linked. Available via https://www.omim.org/entry/300755. Accessed 23 May 2017
  230. OMIM (2011a) Hypoparathyroidism, sensorineural deafness, and renal dysplasia. Available via https://www.omim.org/entry/146255. Accessed 3 June 2017
  231. OMIM (2011b) Townes-Brocks syndrome 1. Available via https://www.omim.org/entry/107480. Accessed 23 May 2017
  232. OMIM (2011c) McCune-Albright Syndrome. Available via https://www.omim.org/entry/174800. Accessed 23 May 2017
  233. OMIM (2012a) Branchiootorenal syndrome 1; BOR1. Available via https://www.omim.org/entry/113650. Accessed 1 May 2017
  234. OMIM (2012b) Marshall syndrome. Available via https://www.omim.org/entry/154780. Accessed 23 May 2017
  235. OMIM (2012c) Muckle-Wells syndrome. Available via https://www.omim.org/entry/191900. Accessed 3 June 2017
  236. OMIM (2012d) Muenke syndrome. Available via https://www.omim.org/entry/602849. Accessed 23 May 2017
  237. OMIM (2012e) Neurofibromatosis, type II. Available via https://www.omim.org/entry/101000. Accessed 23 May 2017
  238. OMIM (2012f) Cockayne syndrome A. Available via https://www.omim.org/entry/216400?search=Cockayne%20syndrome&highlight=syndromic%20cockayne%20syndrome. Accessed 23 May 2017
  239. OMIM (2012g) Pendred syndrome. Available via https://www.omim.org/entry/274600. Accessed 23 May 2017
  240. OMIM (2012h) Usher syndrome, type ID. Available via https://www.omim.org/entry/601067. Accessed 23 May 2017
  241. OMIM (2012i) FG syndrome 4. Available via https://www.omim.org/entry/300422. Accessed 23 May 2017
  242. OMIM (2012j) Diabetes and deafness, maternally inherited. Available via https://www.omim.org/entry/520000. Accessed 23 May 2017
  243. OMIM (2013b) Langer-Giedion syndrome; LGS; chromosome 8q24.1 deletion syndrome. Available via https://www.omim.org/entry/150230?search=Langer-Giedion%20syndrome&highlight=giedion%20syndromic%20langer%20syndrome%20langergiedion. Accessed 3 June 2017
  244. OMIM (2013c) Cleidocranial dysplasia; CCD. Available via https://www.omim.org/entry/119600. Accessed 3 June 2017
  245. OMIM (2013e) Stickler syndrome, type I. Available via https://www.omim.org/entry/108300. Accessed 23 May 2017
  246. OMIM (2013f) Adrenoleukodystrophy. Available via https://www.omim.org/entry/300100. Accessed 3 June 2017
  247. OMIM (2014a) Oculodentodigital dysplasia. Available via https://www.omim.org/entry/164200. Accessed 23 May 2017
  248. OMIM (2014c) Myoclonic epilepsy associated with ragged-red fibers. Available via https://www.omim.org/entry/545000. Accessed 23 May 2017
  249. OMIM (2015a) Down syndrome. Available via https://www.omim.org/entry/190685?search=Morbus%20Down&highlight=down%20morbus. Accessed 3 June 2017
  250. OMIM (2015c) Noonan syndrome 1. Available via https://www.omim.org/entry/163950. Accessed 23 May 2017
  251. OMIM (2015d) Phenylketonuria. Available via https://www.omim.org/entry/261600. Accessed May 23rd, 2017
  252. OMIM (2015e) Mucopolysaccharidosis, type IIIA. Available via https://www.omim.org/entry/252900. Accessed 23 May 2017
  253. OMIM (2015f) Alport syndrome, X-Linked. Available via https://www.omim.org/entry/301050. Accessed 23 May 2017
  254. OMIM (2016a) Hemifacial microsomia; HFM. Available via https://www.omim.org/entry/164210. Accessed 3 June 2017
  255. OMIM (2016b) Charge syndrome. Available via https://www.omim.org/entry/214800. Accessed 3 June 2017
  256. OMIM (2016c) Crouzon syndrome. Available via https://www.omim.org/entry/123500. Accessed 3 June 2017
  257. OMIM (2016d) Treacher Collins syndrome 1. Available via www.omim.org/entry/154500. Accessed 23 May 2017
  258. OMIM (2016e) Waardenburg syndrome, type 1. Available via https://www.omim.org/entry/193500. Accessed 23 May 2017
  259. OMIM (2016f) Alstrom syndrome. Available via https://www.omim.org/entry/203800. Accessed 23 May 2017
  260. OMIM (2016g) Mucopolysaccharidosis, type II. Available via https://www.omim.org/entry/309900. Accessed 23 May 2017
  261. OMIM (2016h) Mucopolysaccharidosis type VI. Available via https://www.omim.org/entry/253200. Accessed 23 May 2017
  262. OMIM (2016i) Hurler syndrome. Available via https://www.omim.org/entry/607014. Accessed 23 May 2017
  263. OMIM (2016j) Mohr-Tranebjaerg syndrome. Available via https://www.omim.org/entry/304700. Accessed 23 May 2017
  264. OMIM (2016k) Kearns-Sayre syndrome. Available via https://www.omim.org/entry/530000. Accessed 23 May 2017
  265. OMIM (2016l) Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Available via https://www.omim.org/entry/540000. Accessed 23 May 2017
  266. OMIM (2017a) Paired box gene 6. Available via https://www.omim.org/entry/607108. Accessed 1 May 2017
  267. OMIM (2017b) Bardet-Biedl syndrome 1. Available via https://www.omim.org/entry/209900. Accessed 23 May 2017
  268. Onakewhor JU, Chiwuzie J (2011) Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria. Niger J Clin Pract 14(2):140–145PubMedCrossRefPubMedCentralGoogle Scholar
  269. Orchik DJ, Rintelmann WF (1978) Comparison of pure-tone, warble-tone and narrow-band noise thresholds of young normal-hearing children. J Am Audiol Soc 3(5):214–220PubMedPubMedCentralGoogle Scholar
  270. Orphanet (2014e) Muckle-Wells syndrome. Available via http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=575. Accessed 1 May 2017
  271. Orphanet (2015d) Maternal phenylketonuria. Available via http://www.orpha.net/consor/www/cgi-bin/OC_Exp.php?lng=EN&Expert=2209. Accessed 3 June 2017
  272. Orvidas LJ, Fabry LB, Diacova S et al (1999) Hearing and otopathology in Crouzon syndrome. Laryngoscope 109(9):1372–1375PubMedCrossRefPubMedCentralGoogle Scholar
  273. Osterhammel D (1978) High-frequency thresholds using a quasi-free-field technique. Scand Audiol 7(1):27–30PubMedCrossRefPubMedCentralGoogle Scholar
  274. Park YH, Shin SH, Byun SW et al (2016) Age- and gender-related mean hearing threshold in a highly-screened population: The Korean National Health and Nutrition Examination Survey 2010-2012. PLoS One 11(3):e0150783PubMedPubMedCentralCrossRefGoogle Scholar
  275. Parry G, Hacking C, Bamford J et al (2003) Minimal response levels for visual reinforcement audiometry in infants. Int J Audiol 42(7):413–417PubMedCrossRefPubMedCentralGoogle Scholar
  276. Parving A (1984) Aetiological diagnosis in hearing-impaired children—clinical value and application of a modern examination programme. Int J Pediatr Otorhinolaryngol 7(1):29–38PubMedCrossRefPubMedCentralGoogle Scholar
  277. Pauli RM (2009) Morquio Syndrome Natural History. Available via http://www.lpaonline.org/assets/documents/NH%20Morquio%20Syndrome.pdf. Accessed 1 Aug 2016
  278. Peterson RG, Simmons MA, Rumack BH et al (1980) Pharmacology of furosemide in the premature newborn infant. J Pediatr 97(1):139–143PubMedCrossRefPubMedCentralGoogle Scholar
  279. Picone O, Vauloup-Fellous C, Cordier AG et al (2009) A 2-year study on cytomegalovirus infection during pregnancy in a French hospital. BJOG 116(6):818–823PubMedCrossRefPubMedCentralGoogle Scholar
  280. Picton TW, Taylor MJ, Durieux-Smith A (2012) Chapter 25—Brainstem auditory evoked potentials in infants and children. In: Aminoff MJ (ed) Electrodiagnosis in clinical neurology, 6th edn. Elsevier Saunders, Philadelphia, pp 553–579CrossRefGoogle Scholar
  281. Pirila T, Jounio-Ervasti K, Sorri M (1992) Left-right asymmetries in hearing threshold levels in three age groups of a random population. Audiology 31(3):150–161PubMedCrossRefPubMedCentralGoogle Scholar
  282. Prulière-Escabasse V, Coste A, Chauvin P et al (2010) Otologic features in children with primary ciliary dyskinesia. Arch Otolaryngol Head Neck Surg 136(11):1121–1126.  https://doi.org/10.1001/archoto.2010.183. PMCID: PMC3307375CrossRefPubMedPubMedCentralGoogle Scholar
  283. Qiao Y, Meng L, Wang J et al (2011) Effect of Ganciclovir on murine cytomegalovirus-induced hearing loss in a mouse model. Cell Biochem Biophys 61(2):407–412PubMedCrossRefPubMedCentralGoogle Scholar
  284. Rais-Bahrami K, Majd M, Veszelovszky E et al (2004) Use of furosemide and hearing loss in neonatal intensive care survivors. Am J Perinatol 21(6):329–332PubMedCrossRefPubMedCentralGoogle Scholar
  285. Rawlinson WD, Boppana SB, Fowler KB et al (2017) Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis 17(6):e177–e188PubMedCrossRefPubMedCentralGoogle Scholar
  286. Richardson K, Peckham CS, Goldstein H (1976) Hearing levels of children tested at 7 and 11 years: a national study. Brit J Audiol 10(4):117–121CrossRefGoogle Scholar
  287. Riga MG, Chelis L, Kakolyris S et al (2011) Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy. Am J Clin Oncol 36(1):1–6CrossRefGoogle Scholar
  288. Rima B (2006) Measles. In: Newton EN, Vallely PJ (eds) Infection and hearing impairment. Whurr, ChichesterGoogle Scholar
  289. Risheg H, Graham J Jr, Clark RD et al (2007) A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome. Nat Genet 39(4):451–453.  https://doi.org/10.1038/ng1992CrossRefPubMedPubMedCentralGoogle Scholar
  290. Roberts J, Ahuja EM (1975) Hearing levels of US youths 12-17 years. Vital and Health Statistics. Series 11. Data from the National Health Survey 145(145):1–84Google Scholar
  291. Roberts J, Federico JV (1972) Hearing sensitivity and related medical findings among children. Vital and Health Statistics. Series 11. Data from the National Health Survey 114(114):1–72Google Scholar
  292. Roberts J, Huber P (1970) Hearing levels of children by age and sex: United States. Vital and health statistics. Series 11. Data from the National Health Survey 102(102):1–51Google Scholar
  293. Rosenthal LS, Fowler KB, Boppana SB et al (2009) Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J 28(6):515–520PubMedPubMedCentralCrossRefGoogle Scholar
  294. Rosner T, Kandzia F, Oswald JA et al (2011) Hearing threshold estimation using concurrent measurement of distortion product otoacoustic emissions and auditory steady-state responses. J Acoust Soc Am 129(2):840–851PubMedCrossRefPubMedCentralGoogle Scholar
  295. Ross SA, Ahmed A, Palmer AL et al (2015) Urine collection method for the diagnosis of congenital cytomegalovirus infection. Pediatr Infect Dis J 34(8):903–905PubMedPubMedCentralCrossRefGoogle Scholar
  296. Santoro L, Hedlund G (2008) FG Syndrome (FGS) FG Syndrome (FGS). European Course on Clinical Dysmorphology Rome, Italy March 28 March 28 - 29, 2008. 40 -Year Retrospective Year Retrospective. Available via http://istituti.unicatt.it/genetica-medica-John_Opitz.pdf. Accessed 23 May 2017
  297. Schacht J, Talaska AE, Rybak LP (2012) Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken) 295(11):1837–1850CrossRefGoogle Scholar
  298. Scheiber C, Hirschfelder S, Gräbel S et al (2009) Bilateral cochlear implantation in children with Noonan syndrome. Int J Pediatr Otorhinolaryngol 73(6):889–894PubMedCrossRefPubMedCentralGoogle Scholar
  299. Schmidt CM, Bartholomaus E, Deuster D et al (2007) Die “Münsteraner Klassifikation”: Eine neue Einteilung der Hochtonschwerhörigkeit nach Cisplatingabe. [The “Muenster classification” of high frequency hearing loss following cisplatin chemotherapy]. HNO 55:299–306PubMedCrossRefPubMedCentralGoogle Scholar
  300. Schmücker M, Deuster D, Lanvers-Kaminsky C et al (2009) Dosisabhängigkeit der Cisplatin-Ototoxizität. In: Gross M, Am Zehnhoff-Dinnesen A (eds) Aktuelle phoniatrisch-pädaudiologische Aspekte 2009, vol 17. Rheinware Verlag, Mönchengladbach, pp 11–12Google Scholar
  301. Schneider B, Trehub SE, Bull D (1980) High-frequency sensitivity in infants. Science (New York, NY) 207(4434):1003–1004CrossRefGoogle Scholar
  302. Scholtz AW, Fish JH 3rd, Kammen-Jolly K et al (2001) Goldenhar’s syndrome: congenital hearing deficit of conductive or sensorineural origin? Temporal bone histopathologic study. Otol Neurotol 22(4):501–505PubMedCrossRefPubMedCentralGoogle Scholar
  303. Schrijver I (2004) Hereditary non-syndromic sensorineural hearing loss: transforming silence to sound. J Mol Diagn 6(4):275824.  https://doi.org/10.1016/S1525-1578(10)60522-3CrossRefGoogle Scholar
  304. Schroeder RJ 2nd, Audlin J, Luo J et al (2018) Pharmacokinetics of sodium thiosulfate in Guinea pig perilymph following middle ear application. J Otol 13(2):54–55PubMedPubMedCentralCrossRefGoogle Scholar
  305. Schuler M, Zimmermann H, Altpeter E et al (2014) Epidemiology of tick-borne encephalitis in Switzerland, 2005 to 2011. Euro Surveill 19(13): pii: 20756PubMedCrossRefPubMedCentralGoogle Scholar
  306. Serin GM, Ciprut A, Baylancicek S et al (2007) Ototoxic effect of Burow solution applied to the guinea pig middle ear. Otol Neurotol 28(5):605–608PubMedPubMedCentralGoogle Scholar
  307. Shargorodsky J, Curhan SG, Curhan GC et al (2010) Change in prevalence of hearing loss in US adolescents. JAMA 304(7):772–778.  https://doi.org/10.1001/jama.2010.1124CrossRefPubMedPubMedCentralGoogle Scholar
  308. Shemen LJ, Mitchell DP, Farkashidy J (1984) Cockayne syndrome-an audiologic and temporal bone analysis. Am J Otol 5(4):300–307PubMedPubMedCentralGoogle Scholar
  309. Shepard NT, Davis JM, Gorga MP et al (1981) Characteristics of hearing-impaired children in the public schools: part I—demographic data. J Speech Hear Disord 46(2):123–129PubMedCrossRefPubMedCentralGoogle Scholar
  310. Silverman SR (1983) Speech training then and now: a critical review. In: Hochberg I et al (eds) Speech of the hearing impaired: research, training, and personnel preparation. University Park Press, Baltimore, pp 1–20Google Scholar
  311. Sinnott JM, Pisoni DB, Aslin RN (1983) A comparison of pure tone auditory thresholds in human infants and adults. Infant Behav Dev 6(1):3–17PubMedPubMedCentralCrossRefGoogle Scholar
  312. Sivri HS, Genç GA, Tokatli A et al (2007) Hearing loss in biotinidase deficiency: genotype-phenotype correlation. J Pediatr 150(4):439–442PubMedCrossRefPubMedCentralGoogle Scholar
  313. Smets K, De Coen K, Dhooge I et al (2006) Selecting neonates with congenital cytomegalovirus infection for ganciclovir therapy. Eur J Pediatr 165(12):885–890PubMedCrossRefPubMedCentralGoogle Scholar
  314. Smith RJH, Shearer AE, Hildebrand MS et al (1993) updated 2014. Deafness and hereditary hearing loss overview. In: Pagon RA et al (eds) GeneReviews(R). University of Washington, Seattle. Available via https://www.ncbi.nlm.nih.gov/books/NBK1434/. Accessed 31 Mar 2017
  315. Smith RJH, Shearer AE, Hildebrand MS (1999) Deafness and hereditary hearing loss overview. In: Pagon RA et al (eds) GeneReviews® [Internet]. University of Washington, Seattle. Available via https://www.ncbi.nlm.nih.gov/books/NBK1434/. Accessed 3 June 2017
  316. Snoeckx RL, Huygen PLM, Feldmann D et al (2005) GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 77(6):945–957.  https://doi.org/10.1086/497996CrossRefPubMedPubMedCentralGoogle Scholar
  317. So TY (2009) Use of ototoxic medications in neonates-the need for follow-up hearing test. J Pediatr Pharmacol Ther 14(4):200–203PubMedPubMedCentralGoogle Scholar
  318. Staab WJ, Rintelmann WF (1972) Status of warble-tone in audiometers. Audiology 11(3):244–255PubMedCrossRefPubMedCentralGoogle Scholar
  319. Staley K, Iragui V, Spitz M (1990) The human fetal auditory evoked potential. Electroencephalogr Clin Neurophysiol 77(1):1–5PubMedCrossRefPubMedCentralGoogle Scholar
  320. Stavroulaki P, Apostolopoulos N, Segas J et al (2001) Evoked otoacoustic emissions—an approach for monitoring cisplatin induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 59(1):47–57CrossRefGoogle Scholar
  321. Steiner A (2013) Bayley scales of infants development-II. In: Volkmar FR (ed) Encyclopedia of autism spectrum disorders. Springer, New York, pp 399–400Google Scholar
  322. Stevens G, Flaxman S, Brunskill E et al (2011) Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries. Eur J Public Health 23(1):146–152PubMedCrossRefPubMedCentralGoogle Scholar
  323. Stevens G, Flaxman S, Brunskill E et al (2013) Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries. Eur J Public Health 23(1):146–152PubMedCrossRefPubMedCentralGoogle Scholar
  324. Stöhr W, Langer T, Kremers A, Bielack S et al (2005) Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance system. Cancer Invest 23(3):201–207PubMedCrossRefPubMedCentralGoogle Scholar
  325. Stowell JD, Forlin-Passoni D, Din E et al (2012) Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission. J Infect Dis 205(2):211–214PubMedCrossRefPubMedCentralGoogle Scholar
  326. Sugiura S, Yoshikawa T, Nishiyama Y et al (2004) Detection of herpesvirus DNAs in perilymph obtained from patients with sensorineural hearing loss by real-time polymerase chain reaction. Laryngoscope 114(12):2235–2238PubMedCrossRefPubMedCentralGoogle Scholar
  327. Swanson EC, Schleiss MR (2013) Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am 60(2):335–349PubMedCrossRefPubMedCentralGoogle Scholar
  328. Talero-Gutierrez C, Carvajalino-Monje I, Samper BS et al (2008) Delayed auditory pathway maturation in the differential diagnosis of hypoacusis in young children. Int J Pediatr Otorhinolaryngol 72(4):519–527PubMedCrossRefPubMedCentralGoogle Scholar
  329. Tamayo ML, García N, Bermúdez Rey MC et al (2013) The importance of fundus eye testing in rubella-induced deafness. Int J Pediatr Otorhinolaryngol 77(9):1536–1540PubMedCrossRefPubMedCentralGoogle Scholar
  330. Teissier N, Delezoide AL, Mas AE et al (2011) Inner ear lesions in congenital cytomegalovirus infection of human fetuses. Acta Neuropathol 122(6):763–774PubMedCrossRefPubMedCentralGoogle Scholar
  331. Tharpe AM (2008) Unilateral hearing loss in children: past and current perspectives. Trends Amplif 12(1):7–15PubMedPubMedCentralCrossRefGoogle Scholar
  332. Thelin JW, Krivenki SE (2008) Audiologic issues in CHARGE syndrome. Available via http://www.asha.org/Articles/Audiologic-Issues-in-CHARGE-Syndrome/. Accessed 11 Jan 2017
  333. Tibesar RJ, Brissett AE, Shallop JK et al (2004) Internal auditory canal decompression and cochlear implantation in Camurati-Engelmann disease. Otolaryngol Head Neck Surg 131(6):1004–1006PubMedCrossRefPubMedCentralGoogle Scholar
  334. Tlumak AI, Durrant JD, Collet L (2007) 80 Hz auditory steady-state responses (ASSR) at 250 Hz and 12,000 Hz. Int J Audiol 46(1):26–30PubMedCrossRefPubMedCentralGoogle Scholar
  335. Tomblin JB, Harrison M, Ambrose SE et al (2015) Language outcomes in young children with mild to severe hearing loss. Ear Hear 36(Suppl 1):76S–91SPubMedPubMedCentralCrossRefGoogle Scholar
  336. Tookey PA (2006) Rubella. In: Newton EN, Vallely PJ (eds) Infection and hearing impairment. Whurr, ChichesterGoogle Scholar
  337. Toriello HV, Smith SD (2013) Hereditary hearing loss and its syndromes, 3rd edn. Oxford University Press, OxfordGoogle Scholar
  338. Torre P III, Zeldow B, Hoffman HJ et al (2012) Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents. Pediatr Infect Dis J 31(8):835–841PubMedPubMedCentralCrossRefGoogle Scholar
  339. Trehub SE, Schneider BA, Endman M (1980) Developmental changes in infants’ sensitivity to octave-band noises. J Exp Child Psychol 29(2):282–293PubMedCrossRefPubMedCentralGoogle Scholar
  340. Trevisan CP, Pastorello E, Tomelleri GL et al (2008) Facioscapulohumeral muscular dystrophy: hearing loss and other atypical features of patients with large 4q35 deletions. Eur J Neurol 15(12):1353–1358PubMedCrossRefPubMedCentralGoogle Scholar
  341. Tunkel D, Alade Y, Kerbavaz R et al (2012) Hearing loss in skeletal dysplasia patients. Am J Med Genet 158A(7):1551–1555.  https://doi.org/10.1002/ajmg.a.35373CrossRefPubMedPubMedCentralGoogle Scholar
  342. Uhler K, Heringer A, Thompson N et al (2012) A tutorial on auditory neuropathy/dyssynchrony for the speech-language pathologist and audiologist. Semin Speech Lang 33(4):354–366PubMedCrossRefPubMedCentralGoogle Scholar
  343. Ulualp SO, Wright CG, Pawlowski KS et al (2004) Histopathological basis of hearing impairment in Wolf-Hirschhorn syndrome. Laryngoscope 114(8):1426–1430PubMedCrossRefPubMedCentralGoogle Scholar
  344. University of Maryland, Medical Center (2014) McCune-Albright syndrome. Available via https://umm.edu/health/medical/ency/articles/mccunealbright-syndrome. Accessed 2 Aug 2016
  345. US Food and Drug Administration (2011) Orphan drug designations and approvals, sodium thiosulfate. Available via http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=353311. Accessed 23 June 2014
  346. US Food and Drug Administration (2012) Orphan drug designations and approvals, N-acetylcysteine. Available via http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=370012. Accessed 23 June 2014
  347. US Preventive Services Task Force (2008) Universal screening for hearing loss in newborns: US Preventive Services Task Force recommendation statement. Pediatrics 122(1):143–148CrossRefGoogle Scholar
  348. van Beelen E, Leijendeckers JM, Huygen PL et al (2012) Audiometric characteristics of two Dutch families with non-ocular Stickler syndrome (COL11A2). Hear Res 291(1–2):15–23PubMedCrossRefPubMedCentralGoogle Scholar
  349. Van Camp G, Smith R (2015) Hereditary hearing loss homepage. Available via http://hereditaryhearingloss.org/. Accessed 3 June 2017
  350. Van Camp G, Smith RJH (2016) Hereditary hearing loss homepage. Available via http://hereditaryhearingloss.org. Accessed 7 June 2016
  351. van Dongen TM, van der Heijden GJ, Venekamp RP et al (2014) A trial of treatment for acute otorrhea in children with tympanostomy tubes. N Engl J Med 370:723–733PubMedCrossRefPubMedCentralGoogle Scholar
  352. Van Naarden Braun K, Christensen D, Doernberg N et al (2015) Trends in the prevalence of autism spectrum disorder, cerebral palsy, hearing loss, intellectual disability, and vision impairment, metropolitan Atlanta, 1991-2010. PLoS One 10(4):e0124120PubMedPubMedCentralCrossRefGoogle Scholar
  353. Vieira EP, Azevedo MF (2007) Audiometria de reforço visual com diferentes estímulos sonorous em crianças. (Visual reinforcement audiometry with different sound stimuli in children). Pro Fono 19(2):185–194PubMedCrossRefPubMedCentralGoogle Scholar
  354. Waissbluth S, Daniel SJ (2013) Cisplatin-induced ototoxicity: transporters playing a role in cisplatin toxicity. Hear Res 299:37–45PubMedCrossRefPubMedCentralGoogle Scholar
  355. Walker G, Dillon H, Byrne D (1984) Sound field audiometry: recommended stimuli and procedures. Ear Hear 5(1):13–21PubMedCrossRefPubMedCentralGoogle Scholar
  356. Wang D, Fu TM (2014) Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease. Curr Opin Virol 6:13–23PubMedCrossRefPubMedCentralGoogle Scholar
  357. Wang X, Fernandez R, Tsivkovskaia N et al (2014) OTO-201: nonclinical assessment of a sustained-release ciprofloxacin hydrogel for the treatment of otitis media. Otol Neurotol 35(3):459–469PubMedPubMedCentralCrossRefGoogle Scholar
  358. Warrier R, Chauhan A, Davluri M et al (2012) Cisplatin and cranial irradiation-related hearing loss in children. Ochsner J 12(3):191–196PubMedPubMedCentralGoogle Scholar
  359. Watkin PM, Baldwin M, Laoide S (1990) Parental suspicion and identification of hearing impairment. Arch Dis Child 65(8):846–850PubMedPubMedCentralCrossRefGoogle Scholar
  360. WebMD Magazine (2007) McCune Albright syndrome. Available via http://www.webmd.com/children/mccune-albright-syndrome. Accessed 2 Aug 2016
  361. Weichbold V, Nekahm-Heis D, Welzl-Muller K (2006) Universal newborn hearing screening and postnatal hearing loss. Pediatrics 117(4):631–636CrossRefGoogle Scholar
  362. Weissenstein A, Deuster D, Knief A et al (2012) Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy. Int J Pediatr Otorhinolaryngol 76(1):131–136PubMedCrossRefPubMedCentralGoogle Scholar
  363. Welch KO, Marin RS, Pandya A et al (2007) Compound heterozygosity for dominant and recessive GJB2 mutations: effect on phenotype and review of the literature. Am J Med Genet A 143A(14):1567–1573.  https://doi.org/10.1002/ajmg.a.31701CrossRefPubMedPubMedCentralGoogle Scholar
  364. Westerberg BD, Atashband S, Kozak FK (2008) A systematic review of the incidence of sensorineural hearing loss in neonates exposed to Herpes simplex virus (HSV). Int J Pediatr Otorhinolaryngol 72(7):931–937PubMedCrossRefPubMedCentralGoogle Scholar
  365. White DR, Choo DI, Stroup G et al (2006) The effect of cidofovir on cytomegalovirus-induced hearing loss in a guinea pig model. Arch Otolaryngol Head Neck Surg 132(6):608–615PubMedCrossRefPubMedCentralGoogle Scholar
  366. WHO (2013) WHO methods and data sources for global burden of disease estimates 2000-2011. Available via http://www.who.int/healthinfo/statistics/GlobalDALYmethods_2000_2011.pdf. Accessed 4 May 2017
  367. Williamson T (2002) Neonatal hearing screening and assessment behavioural observation audiometry. A recommended test protocol. Available via http://hearing.screening.nhs.uk/audiology. Accessed 19 Sept 2014
  368. Wilson WR, Gulya AJ (1993) Sudden sensorineural hearing loss. In: Cummings CW, Fredrickson JF, Harker LA et al (eds) Otolaryngology: head and neck surgery, vol 4, 2nd edn. Mosby-Year Book Inc, St. LouisGoogle Scholar
  369. Winiger AM, Alexander JM, Diefendorf AO (2016) Minimal hearing loss: from a failure-based approach to evidence-based practice. Am J Audiol 25(3):232–245PubMedCrossRefPubMedCentralGoogle Scholar
  370. Woodin M, Wang PP, Aleman D et al (2001) Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet Med 3(1):34–39.  https://doi.org/10.1097/00125817-200101000-00008CrossRefPubMedPubMedCentralGoogle Scholar
  371. Woods JR, Plessinger MA (1985) The fetal auditory brain stem response: serial measurements at two stimulus intensities. Otolaryngol Head Neck Surg 93(6):759–764PubMedCrossRefPubMedCentralGoogle Scholar
  372. World Health Organization (2013) WHO methods and data sources for global burden of disease estimates 2000-2011. WHO, Geneva. Available via http://www.who.int/healthinfo/statistics/GlobalDALYmethods_2000_2011.pdf. Accessed 4 Jan 2017
  373. Wright KE (2006) Mumps. In: Newton EN, Vallely PJ (eds) Infection and hearing impairment. Whurr, ChichesterGoogle Scholar
  374. Wright E, Brew B, Wesselingh S (2008) Pathogenesis and diagnosis of viral infections of the nervous system. Neurol Clin 26(3):617–733PubMedCrossRefPubMedCentralGoogle Scholar
  375. Yang TH, Wu CS, Liao WH et al (2011) Mean hearing thresholds among school children in Taiwan. Ear Hear 32(2):258–265PubMedCrossRefPubMedCentralGoogle Scholar
  376. Yesiltepe Mutlu G, Kirmizibekmez H, Nakamura A et al (2015) Novel de novo GATA binding protein 3 mutation in a Turkish boy with hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Res Pediatr Endocrinol 7(4):344–348.  https://doi.org/10.4274/jcrpe.2249CrossRefPubMedPubMedCentralGoogle Scholar
  377. Yoshinaga-Itano C, AL S, Coulter DK et al (1998) Language of early- and later-identified children with hearing loss. Pediatrics 102(5):1161–1171CrossRefGoogle Scholar
  378. Yoshinaga-Itano C, Johnson CD, Carpenter K et al (2009) Outcomes of children with mild bilateral hearing loss and unilateral hearing loss. Sem Hear 29(2):196–211CrossRefGoogle Scholar
  379. Zarchi O, Attias J, Raveh E et al (2011) A comparative study of hearing loss in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes. J Pediatr 158(2):301–306.  https://doi.org/10.1016/j.jpeds.2010.07.056. Epub 2010 Sep 16CrossRefPubMedPubMedCentralGoogle Scholar
  380. Zumach A, Gerrits E, Chenault MN et al (2009) Otitis media and speech-in-noise recognition in school-aged children. Audiol Neurootol 14(2):121–129PubMedCrossRefPubMedCentralGoogle Scholar
  381. Zwirner P, Wilichowski E (2001) Progressive sensorineural hearing loss in children with mitochondrial encephalomyopathies. Laryngoscope 111(3):515–521PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2020

Authors and Affiliations

  • Antoinette am Zehnhoff-Dinnesen
    • 1
    Email author
  • Wendy Albuquerque
    • 2
  • Hanno J. Bolz
    • 3
  • Steffi Johanna Brockmeier
    • 4
  • Thorsten Langer
    • 5
  • Radha Narayan
    • 6
  • Ross Parfitt
    • 1
  • Simona Poisson-Markova
    • 7
  • Ewa Raglan
    • 8
  • Sabrina Regele
    • 1
  • Rainer Schönweiler
    • 9
  • Pavel Seeman
    • 7
  • Eva Seemanova
    • 7
  • Amélie Elisabeth Tillmanns
    • 1
  • Oliver Zolk
    • 10
  1. 1.Clinic of Phoniatrics and PedaudiologyUniversity Hospital MünsterMünsterGermany
  2. 2.Department of ENT and Audiovestibular Medicine, St Georges Healthcare NHS TrustLondonUK
  3. 3.Senckenberg Centre for Human GeneticsFrankfurt am MainGermany
  4. 4.ENT Clinic, Audiology, Phoniatrics, Neuro-OtologyKantonsspital Aarau AGAarauSwitzerland
  5. 5.Department of Pediatric Oncology and HematologyUniversity Hospital Schleswig-Holstein, Campus LübeckLübeckGermany
  6. 6.The Whittington HospitalLondonUK
  7. 7.Department of Child Neurology2nd Medical School of Charles University PraguePragueCzech Republic
  8. 8.Department of Audiology and Audiovestibular MedicineGreat Ormond Street Hospital for Children NHS Foundation TrustLondonUK
  9. 9.Department of Phoniatrics and Pediatric AudiologyUniversity Clinic of Schleswig-Holstein, Campus LübeckLübeckGermany
  10. 10.Institute of Pharmacology of Natural Products and Clinical Pharmacology, University Hospital UlmUlmGermany

Personalised recommendations